• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Eris Lifesciences Limited — Board Meeting, 12-11-2025: Outcome of Board Meeting

    12-11-2025 | 01:36 pm

    Eris Lifesciences' board approved strong Q2 & H1 consolidated financials: Q2 revenue hit ₹792.41 Cr, net profit ₹120.19 Cr. H1 revenue was ₹1,565.41 Cr, net profit ₹238.18 Cr. They also proposed re-appointments of two directors for five-year terms.

    No comments yet. Be the first to comment!

    All announcements from Eris Lifesciences Limited